Title:
A SUSTAINED RELEASE PHARMACEUTICAL DOSAGE FORM OF DIVALPROEX
Document Type and Number:
WIPO Patent Application WO/2017/163268
Kind Code:
A3
Abstract:
A sustained release pharmaceutical dosage form comprising divalproex or its salt and rate controlling polymer, wherein when one or more units of the sustained release pharmaceutical dosage form comprising a reduced total daily dose of divalproex or its salt, is/are administered once daily, therapeutically effective levels of divalproex for treating acute manic or mixed episodes associated with bipolar disorders with or without pyschotic features, complex partial seizures and simple and complex absence seizures or migraine are obtained.
Inventors:
SUHAGIYA VISHAL (IN)
NATHAMANI T (IN)
KULKARNI AMOL (IN)
KULKARNI SHIRISH (IN)
THENNATI RAJAMANNAR (IN)
NATHAMANI T (IN)
KULKARNI AMOL (IN)
KULKARNI SHIRISH (IN)
THENNATI RAJAMANNAR (IN)
Application Number:
PCT/IN2017/050107
Publication Date:
January 11, 2018
Filing Date:
March 23, 2017
Export Citation:
Assignee:
SUN PHARMACEUTICAL IND LTD (IN)
International Classes:
A61K31/19; A61K9/28
Domestic Patent References:
| WO2009008004A2 | 2009-01-15 | |||
| WO2008032208A2 | 2008-03-20 | |||
| WO2003103635A1 | 2003-12-18 |
Foreign References:
| US20010005512A1 | 2001-06-28 | |||
| US5185159A | 1993-02-09 |
Download PDF:
Previous Patent: AN IMPROVED METHOD OF ADMINISTERING DIVALPROEX
Next Patent: A MULTILAYERED FUSED TILE AND A METHOD FOR MAKING THE SAME
Next Patent: A MULTILAYERED FUSED TILE AND A METHOD FOR MAKING THE SAME